Article Text

SP0201 New Developments in Antiphospholipid Syndrome
  1. D. D'Cruz
  1. Louise Coote Lupus Unit, Guys and St Thomas' Hospitals, London, United Kingdom


Antiphospholipid syndrome (APS) is characterised by recurrent pregnancy morbidity and venous and arterial thromobotic events. Considerable progress has been made in understanding the mechanisms of thrombosis and pregnancy loss which have led to improved clinical outcomes for patients. APS vasculopathy is characterised by vascular intimal hyperplasia which may lead to stenotic lesions in the renal arteries resulting in hypertension. APS nephropathy may lead to renal impairment. However, renal biopsy is associated with significantly increased risks of bleeding complications as a result of renal vessel intimal hyperplasia. This brief lecture will review recent developments in APS nephropathy and will address the risks of renal biopsy and strategies to minimise biopsy complications.

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.